Reduced COX-2 expression in aged mice is associated with impaired fracture healing

Amish A Naik1, Chao Xie, Michael J Zuscik

  • 1The Center for Musculoskeletal Research, University of Rochester, Rochester, New York 14642, USA.

Insights

Aging impairs fracture healing by reducing cyclooxygenase 2 (COX-2) expression. Supplementing with COX-2/EP4 agonists in aged mice improved bone repair, suggesting a therapeutic target for age-related healing deficits.

Area of Science:

  • Biomedical Sciences
  • Orthopedics
  • Regenerative Medicine

Background:

  • Fracture healing is impaired with aging, but the underlying cellular and molecular mechanisms remain unclear.
  • Cyclooxygenase 2 (COX-2), a key regulator of prostaglandin E(2) (PGE(2)), is crucial for normal bone repair.

Purpose of the Study:

  • To investigate the role of COX-2 in age-related fracture healing deficits.
  • To explore the potential of COX-2/EP4 agonists to enhance fracture repair in aged individuals.

Main Methods:

  • A femoral fracture repair model was utilized in young (7-9 weeks) and aged (52-56 weeks) mice.
  • Healing was assessed using imaging, histology, and gene expression analysis.
  • COX-2 expression levels were quantified, and the effect of an EP4 agonist on aged mice was evaluated.

Main Results:

  • Aging significantly reduced chondrogenesis, bone formation, callus vascularization, and remodeling, alongside altered gene expression.
  • COX-2 expression was markedly decreased in aged mice compared to young mice during fracture healing.
  • Local administration of an EP4 agonist in aged mice restored chondrogenesis and bone formation to levels seen in young mice.

Conclusions:

  • Reduced COX-2 expression during the early inflammatory phase of fracture repair contributes to age-related healing impairments.
  • COX-2/EP4 agonists show promise in compensating for deficient molecular signals and improving fracture healing in aged populations.